Proton Intelligence
- Focus
- Continuous potassium monitoring
- Location
- Vancouver
- Investment date
- Dec. 2024
Proton Intelligence is disrupting the management of cardio-kidney-metabolic diseases with its groundbreaking Continuous Potassium Monitoring (CKM™) platform. CKM™ provides real-time potassium level insights, addressing the critical need for timely and actionable data in patient care. By overcoming the challenges of monitoring this vital biomarker, Proton empowers clinicians and patients to mitigate life-threatening risks like cardiac arrhythmias and sudden cardiac death.